Trial Profile
Retrospective, interventional, case series, treat and extend study of ranibizumab and bevacizumab in patients with age related macular degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Pharmacodynamics; Therapeutic Use
- 25 Nov 2015 New trial record